What does an incidence of 3 per 100 person‑years mean?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Understanding "3 per 100 Person-Years"

An incidence of 3 per 100 person-years means that in a population followed over time, 3 new cases of a disease or event occur for every 100 people followed for one year, or equivalently, 3 cases per 100 total years of observation across all individuals in the study.

What This Metric Represents

Person-years is a measure that accounts for both the number of people in a study and the length of time each person is observed 1, 2, 3. This approach is particularly useful when:

  • People enter or leave the study at different times 2, 3
  • Follow-up duration varies between individuals 1, 4
  • The observation period is extended over multiple years 3, 5

Practical Interpretation

To understand "3 per 100 person-years," consider these equivalent scenarios 3, 4:

  • 100 people followed for 1 year = 100 person-years of observation, expecting 3 new cases
  • 50 people followed for 2 years = 100 person-years of observation, expecting 3 new cases
  • 200 people followed for 6 months = 100 person-years of observation, expecting 3 new cases

Real-World Clinical Examples

The medical literature provides concrete examples of this metric in use:

  • HCV reinfection rates range from 1.81 per 100 person-years in hospital clinics to 31 per 100 person-years among active people who inject drugs 6
  • Hepatocellular carcinoma incidence in alcohol-related cirrhosis is approximately 2.9 per 100 person-years 6
  • Heart failure incidence ranges from 3.2 to 8.1 per 1000 person-years (or 0.32 to 0.81 per 100 person-years) depending on the population 6
  • Stroke incidence in Hodgkin disease survivors after radiation was 83.6 per 100,000 person-years (or 0.084 per 100 person-years) 6

Key Advantages of This Measure

Person-years methodology offers several benefits over simple proportions 2, 3, 4:

  • Accounts for variable follow-up time when participants are observed for different durations 2
  • Handles censoring when people drop out or are lost to follow-up 1, 4
  • Provides rate information that reflects the speed at which events occur in the population 3, 5

Important Caveats

While person-years is widely used, it has limitations 1:

  • Assumes constant hazard over time, which rarely applies in medical research 1
  • Can yield misleading results when the risk of disease changes substantially over the observation period 1
  • May be ambiguous when comparing populations with very different follow-up patterns 1

When the constant hazards assumption doesn't hold, survival analysis methods may provide more accurate risk estimates than simple person-years calculations 1.

References

Research

Measures of disease frequency: prevalence and incidence.

Nephron. Clinical practice, 2010

Research

Let me count the ways: measuring incidence, prevalence, and impact in epidemiological studies.

Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1998

Research

Prevalence, incidence and duration.

American journal of epidemiology, 1980

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

How should nasal congestion be managed in a 1‑month‑old infant?
How many milliliters of a 2 mg/mL solution are needed to administer a 0.5 mg dose?
How should I manage a neonate with an oxygen saturation of 80%?
In a 17-year-old with dyspnea and chest pain, a normal electrocardiogram (ECG) and normal chest radiograph, which laboratory tests should be ordered?
What are the possible causes and recommended evaluation for a 4‑month‑old female infant who cannot lift her arm above her head?
What is the appropriate management for a 7-year-old male with mixed nephrotic‑nephritic syndrome secondary to confirmed IgA nephropathy presenting with oliguria, hematuria, and generalized edema?
In a 25‑year‑old obese male with borderline diabetes (previously on metformin) and elevated blood pressure (135/95 mm Hg) who experiences episodic spasm‑like epigastric pain after meals, lasting about a day, relieved by sleep, and followed by watery brown type‑6 diarrhea, what are the most likely diagnoses and the appropriate initial work‑up and management steps?
What are the side effects and contraindications of EPA‑predominant omega‑3, L‑methylfolate, S‑adenosylmethionine (SAMe), saffron extract, cholecalciferol (vitamin D), N‑acetylcysteine, and zinc?
What is the recommended antiviral regimen for a dialysis patient with acute herpes zoster (shingles)?
Can walnuts provide enough omega‑3 fatty acids (EPA/DHA) as a natural alternative to fish‑oil supplements?
What is the appropriate management for a patient with upper‑mid rectal wall thickening and mesorectal fat stranding on MRI, small presacral/mesorectal lymph nodes, and colonoscopic biopsy showing a villous adenoma with high‑grade dysplasia where invasive carcinoma cannot be excluded?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.